David E. I. Pyott

President at International Council of Ophthalmology Foundation

David E. I. Pyott

David E. I. Pyott

President at International Council of Ophthalmology Foundation

Overview
Career Highlights

International Council of Ophthalmology Foundation
Allergan Specialty Therapeutics, Inc.
Vicept Therapeutics, Inc.

RelSci Relationships

4148

Number of Boards

33

Birthday

1954

Age

66

Number of Awards

6

Relationships
RelSci Relationships are individuals David E. I. Pyott likely has professional access to. A relationship does not necessarily indicate a personal connection.

Former Chief Financial Officer at Allergan Specialty Therapeutics, Inc.

Relationship likelihood: Strong

President & Chief Executive Officer at Sarepta Therapeutics, Inc.

Relationship likelihood: Strong

Dean Emeritus at Johns Hopkins Bloomberg School of Public Health

Relationship likelihood: Strong

Chairman of the Board, President & Chief Executive Officer at Avery Dennison Corporation

Relationship likelihood: Strong

Former Chief Executive Officer at Avery Dennison Corporation

Relationship likelihood: Strong

Former Executive Vice President, Finance & Business Development & Chief Financial Officer at Allergan, Inc.

Relationship likelihood: Strong

Former President & Chief Executive Officer at Alcon, Inc.

Relationship likelihood: Strong

President & Chief Executive Officer at H. Lundbeck A/S

Relationship likelihood: Strong

Chief Executive Officer at Alnylam Pharmaceuticals, Inc.

Relationship likelihood: Strong

Chairman, President & Chief Executive Officer at The Allergan Foundation

Relationship likelihood: Strong

Paths to David E. I. Pyott
Potential Connections via
Relationship Science
You
David E. I. Pyott
President at International Council of Ophthalmology Foundation
Education
Master of Arts

The University of Edinburgh, founded in 1583, is a public research university in Edinburgh, the capital of Scotland. It was the fourth university to be established in Scotland and the sixth in the United Kingdom, and is one of the most prestigious universities in the world. Edinburgh receives approximately 47,000 applications every year, making it the third most popular university in the UK by volume of applicants. Entrance is intensely competitive, with offer chances of 27% in the 2010-2011 admissions cycle. The university is deeply embedded in the fabric of the city, with many of the buildings in the historic Old Town belonging to the university.

Diploma in International & European Law

The University of Amsterdam is one of the world’s intellectual hubs with a rich history dating back to 1632

Memberships
Member
Current

The participating CEOs lead companies that collectively employ more than five million people, generate more than $2 trillion in annual revenue, and represent 11 countries and a diverse group of industries.

Career History
President
2012 - Current

THE ORGANIZATION IS DEDICATED TO THE SUPPORT OF PROGRAMS THAT WILL ELEVATE THE LEVEL OF OPHTHALMIC EDUCATION WORLDWIDE.

Strategic Advisor to the Chief Executive Officer
Current

Sienna Biopharmaceuticals, Inc. is a clinical-stage biopharmaceutical company that focuses on the discovery, clinical development, and commercialization of aesthetics and medical dermatology. Its products include Topical by Design platform for patients with inflammatory skin diseases and other dermatologic and aesthetic conditions through SNA-120, SNA-125, and SNA-001. The company was founded by Todd Harris and Frederick C. Beddingfield III on July 27, 2010 and is headquartered in Westlake Village, CA.

Director
Tenure Unconfirmed

Avery Dennison Corp. engages in the provision of labeling and packaging materials and solutions. Its businesses include the production of pressure-sensitive materials and a variety of tickets, tags, labels, and other converted products. The company operates through the following business segments: Label & Graphic Materials, Retail Branding & Information Solutions, and Industrial & Healthcare Materials. The Label and Graphic Materials Segment manufactures and sells Fasson, JAC, and Avery Dennison-brand pressure-sensitive label and packaging materials, Avery Dennison and Mactac brand graphics, and Avery Dennison brand reflective products. The Retail Branding and Information Solutions segment designs, manufactures, and sells a variety of branding and information solutions to retailers, brand owners, apparel manufacturers, distributors and industrial customers. The Industrial and Healthcare Materials Segment manufactures and sells Fasson-brand and Avery Dennison-brand tapes and fasteners, Vancive -brand medical pressure sensitive adhesive based materials and products, and performance polymers. Avery Dennison was founded by R. Stanton Avery in 1935 and is headquartered in Glendale, CA.

Boards & Committees
Member, Board of Directors
Prior - 2015
Director
Prior

Pacific Mutual Holding Co. engages in the provision of insurance, financial services, and other investment-related businesses. It operates through the following segments: Life Insurance, Retirement Solutions, Aircraft Leasing, Reinsurance, and Corporate and Other. The Life Insurance segment includes universal life, indexed universal life, variable universal life, hybrid long term care, and term life insurance. The Retirement Solutions segment involves variable and fixed annuity products; mutual funds, and structured settlement and group retirement annuities which are offered through multiple distribution channels. The Aircraft Leasing segment offers aircraft leasing to the airline industry and provides brokerage and asset management services to other third parties. The Reinsurance segment provides reinsurance to insurance and annuity providers in the United Kingdom, Ireland, and Australia. The Corporate and Other segment consists of assets, liabilities, and activities which support the other operating segments of the firm. The company was founded in 1997 and is headquartered in Newport Beach, CA.

Chairman
Prior - 2016
Non-Profit Donations & Grants

Learn how non-profit organizations benefit from RelSci
$1,000 - $4,999
2016

THE CORPORATION WAS FORMED TO PROMOTE, SUPPORT AND OTHERWISE ENGAGE IN RESEARCH AND EDUCATION CONCERNING THE NATURE, CAUSES AND TREATMENT OF GLAUCOMA AND RELATED DISEASES OF THE EYE.

$10K - $25K
2010

THE ORGANIZATION IS DEDICATED TO THE SUPPORT OF PROGRAMS THAT WILL ELEVATE THE LEVEL OF OPHTHALMIC EDUCATION WORLDWIDE.

$5,000 - $10K
2009

Cancer Care, Inc. provides cancer treatment services. The firm's services include counseling and support groups, education, financial assistance and practical help. The company was founded in 1944 and is headquartered in New York, NY.

Political Donations
$10K
2015

Senior Strategic Advisor at Squire Patton Boggs LLP

$10K
2014

Senior Strategic Advisor at Squire Patton Boggs LLP

$32.4K
2014

The National Republican Senatorial Committee (NRSC) is the only national organization solely devoted to electing Republicans to the U.S. Senate. The NRSC provides invaluable support and assistance to current and prospective Republican U.S. Senate candidates in the areas of budget planning, election law compliance, fundraising, communications tools and messaging, research and strategy.

Transactions
Details Hidden

Apollo Endosurgery, Inc. (Inactive), CPMG, PTV Sciences LP, Novo Ventures, H.I.G. BioHealth Partners LLC purchase Allergan, Inc. /Obesity Intervention Business from Allergan, Inc.

Investments
Details Hidden

Mellon Medical BV manufactures and develops surgical suturing devices. The firm's suturing device, the Switch, is designed for surgeons who perform the challenging operations and can easily be rotated in the hand because of its pencil-like shape. The company was founded in April 2013 by Mark Vrancken Peeters and is headquartered in Nijmegen, the Netherlands.

Details Hidden

Sienna Biopharmaceuticals, Inc. is a clinical-stage biopharmaceutical company that focuses on the discovery, clinical development, and commercialization of aesthetics and medical dermatology. Its products include Topical by Design platform for patients with inflammatory skin diseases and other dermatologic and aesthetic conditions through SNA-120, SNA-125, and SNA-001. The company was founded by Todd Harris and Frederick C. Beddingfield III on July 27, 2010 and is headquartered in Westlake Village, CA.

Details Hidden

Bioniz Therapeutics, Inc. is a biopharmaceutical firm, which engages in the development of peptide therapeutics that selectively and simultaneously inhibit multiple cytokines for the treatment of immune diseases and cancer. The company was founded by Nazli Azimi on December 16, 2015 and is headquartered in Irvine, CA.

Public Holdings
Restricted data only for RelSci Professional users.
Awards & Honors
Rank #80
2014
Chief Executive Magazine - Wealth Creators
Rank #45
2014
Fortune Magazine - Business Person of the Year
Rank #4
2014
Harvard Business Review - 100 Best-Performing CEOs in the World
Events
Attendee
Washington, DC, United States
2010 Wall Street Journal CEO Council Annual Meeting

Wall Street Journal’s annual CEO Council meeting released specific priorities that both government and business must address to restore global growth and to increase public confidence in business. The plans voted by CEO Council members as the top two priorities each focused on job creation – leading with a call to foster global trade, followed by a call for the president to encourage a competitive business environment and be an advocate for business in general. The CEO Council worked together in task force sessions charged with identifying and ranking the most urgent priorities. Leading subject-matter experts provided key perspectives and information for the discussion, which focused on five key topics: fresh approaches to energy and the environment, the future of global finance, creating sustainable jobs, restoring confidence in business and next step for healthcare.

This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by David E. I. Pyott. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of David E. I. Pyott's profile does not indicate a business or promotional relationship of any kind between RelSci and David E. I. Pyott.